N,3,3-TriMethyl-1,5-dioxaspiro[5.5]undecan-9-aMine
- $85 - $1593.9
- Product name: N,3,3-TriMethyl-1,5-dioxaspiro[5.5]undecan-9-aMine
- CAS: 158747-11-6
- MF: C12H23NO2
- MW: 213.32
- EINECS:
- MDL Number:MFCD08669807
- Synonyms:4-Methylamino-cyclohexanone(2’,2’-dimethyltrimethylene ketal);N,3,3-TriMethyl-1,5-dioxaspiro[5.5]undecan-9-aMine;1,5-Dioxaspiro[5.5]undecan-9-amine, N,3,3-trimethyl-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- TRC
Package
- 5mg
- 10MG
- 100MG
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0145644
- Product description4-(METHYLAMINO)CYCLOHEXANONE 2,2-DIMETHYLTRIMETHYLENE KETAL 95.00%
- Packaging100MG
- Price$1593.9
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0145644
- Product description4-(METHYLAMINO)CYCLOHEXANONE 2,2-DIMETHYLTRIMETHYLENE KETAL 95.00%
- Packaging10MG
- Price$704.55
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM285940
- Product description4-Methylamino-cyclohexanone(2’,2’-dimethyltrimethyleneketal)
- Packaging5mg
- Price$85
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0145644 | 4-(METHYLAMINO)CYCLOHEXANONE 2,2-DIMETHYLTRIMETHYLENE KETAL 95.00% | 100MG | $1593.9 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0145644 | 4-(METHYLAMINO)CYCLOHEXANONE 2,2-DIMETHYLTRIMETHYLENE KETAL 95.00% | 10MG | $704.55 | 2021-12-16 | Buy |
TRC | M285940 | 4-Methylamino-cyclohexanone(2’,2’-dimethyltrimethyleneketal) | 5mg | $85 | 2021-12-16 | Buy |
Properties
Boiling point :293.3±40.0 °C(Predicted)
Density :1.01±0.1 g/cm3(Predicted)
solubility :Acetone, Methanol
pka :10.65±0.40(Predicted)
Density :1.01±0.1 g/cm3(Predicted)
solubility :Acetone, Methanol
pka :10.65±0.40(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|